Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin (Q43826389)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 March 2013
edit
Language Label Description Also known as
English
Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin
scientific article published on 24 March 2013

    Statements

    Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metformin (English)
    M Leonsson-Zachrisson
    C Wessman
    E Johnsson
    24 March 2013
    750-759

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit